196 related articles for article (PubMed ID: 27120570)
1. Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study.
Nguyen GC; Croitoru K; Silverberg MS; Steinhart AH; Weizman AV
Inflamm Bowel Dis; 2016 Jun; 22(6):1412-7. PubMed ID: 27120570
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478
[TBL] [Abstract][Full Text] [Related]
3. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
[TBL] [Abstract][Full Text] [Related]
4. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.
Lakatos PL; Czegledi Z; David G; Kispal Z; Kiss LS; Palatka K; Kristof T; Nagy F; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovacs A; Racz I; Lakatos L
J Crohns Colitis; 2010 Sep; 4(3):283-90. PubMed ID: 21122517
[TBL] [Abstract][Full Text] [Related]
5. Complementary and alternative medicine use and its association with medication adherence in inflammatory bowel disease and other gastrointestinal diseases.
Almakadma AH; De Vol A; Alabdaljabar MS; Aldosari S; Muhsen I; AlFreihi O; Kurdi A; Almadi M; Alsohaibani F
Saudi J Gastroenterol; 2023; 29(4):233-239. PubMed ID: 37282444
[TBL] [Abstract][Full Text] [Related]
6. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey.
Abitbol V; Lahmek P; Buisson A; Olympie A; Poupardin C; Chaussade S; Lesgourgues B; Nahon S
Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):288-94. PubMed ID: 24407360
[TBL] [Abstract][Full Text] [Related]
7. Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study.
Koning M; Ailabouni R; Gearry RB; Frampton CM; Barclay ML
Inflamm Bowel Dis; 2013; 19(4):767-78. PubMed ID: 23429459
[TBL] [Abstract][Full Text] [Related]
8. Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).
Opheim R; Hoivik ML; Solberg IC; Moum B;
J Crohns Colitis; 2012 Apr; 6(3):345-53. PubMed ID: 22405172
[TBL] [Abstract][Full Text] [Related]
9. Experiences of complementary and alternative medicine in patients with inflammatory bowel disease - a qualitative study.
Lindberg A; Fossum B; Karlen P; Oxelmark L
BMC Complement Altern Med; 2014 Oct; 14():407. PubMed ID: 25338541
[TBL] [Abstract][Full Text] [Related]
10. Identifying predictors of low adherence in patients with inflammatory bowel disease.
Coenen S; Weyts E; Ballet V; Noman M; Van Assche G; Vermeire S; Van Emelen J; Ferrante M
Eur J Gastroenterol Hepatol; 2016 May; 28(5):503-7. PubMed ID: 26760588
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Bowel Disease Pharmacist Adherence Counseling Improves Medication Adherence in Crohn's Disease and Ulcerative Colitis.
Tiao DK; Chan W; Jeganathan J; Chan JT; Perry J; Selinger CP; Leong RW
Inflamm Bowel Dis; 2017 Aug; 23(8):1257-1261. PubMed ID: 28719539
[TBL] [Abstract][Full Text] [Related]
12. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey.
Langhorst J; Anthonisen IB; Steder-Neukamm U; Lüdtke R; Spahn G; Michalsen A; Dobos GJ
Inflamm Bowel Dis; 2005 Mar; 11(3):287-95. PubMed ID: 15735435
[TBL] [Abstract][Full Text] [Related]
13. Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use.
Langhorst J; Anthonisen IB; Steder-Neukamm U; Luedtke R; Spahn G; Michalsen A; Dobos GJ
Complement Ther Med; 2007 Mar; 15(1):30-7. PubMed ID: 17352969
[TBL] [Abstract][Full Text] [Related]
14. Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index.
de Castro ML; Sanromán L; Martín A; Figueira M; Martínez N; Hernández V; Del Campo V; Pineda JR; Martínez-Cadilla J; Pereira S; Rodríguez Prada JI
Rev Esp Enferm Dig; 2017 Aug; 109(8):542-551. PubMed ID: 28679280
[TBL] [Abstract][Full Text] [Related]
15. Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway.
Opheim R; Bernklev T; Fagermoen MS; Cvancarova M; Moum B
Scand J Gastroenterol; 2012 Dec; 47(12):1436-47. PubMed ID: 23003678
[TBL] [Abstract][Full Text] [Related]
16. Importance of Patients' Knowledge of Their Prescribed Medication in Improving Treatment Adherence in Inflammatory Bowel Disease.
Tae CH; Jung SA; Moon HS; Seo JA; Song HK; Moon CM; Kim SE; Shim KN; Jung HK
J Clin Gastroenterol; 2016 Feb; 50(2):157-62. PubMed ID: 26501880
[TBL] [Abstract][Full Text] [Related]
17. Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease.
Selinger CP; Eaden J; Jones DB; Katelaris P; Chapman G; McDonald C; Smith P; Lal S; Leong RW; McLaughlin J; Robinson A
Inflamm Bowel Dis; 2013 Sep; 19(10):2199-206. PubMed ID: 23899547
[TBL] [Abstract][Full Text] [Related]
18. Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Diseases: A Single-Center Survey.
Serpico MR; Boyle BM; Kemper KJ; Kim SC
J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):651-657. PubMed ID: 26960176
[TBL] [Abstract][Full Text] [Related]
19. Use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD): results from a German nationwide survey of 2019 compared to a previous survey of 2002.
Bauer N; Kairey L; Schlee C; Uecker C; Öznur Ö; Langhorst J
Scand J Gastroenterol; 2022 Oct; 57(10):1209-1215. PubMed ID: 35722930
[TBL] [Abstract][Full Text] [Related]
20. Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study.
Bertomoro P; Renna S; Cottone M; Riegler G; Bossa F; Giglio L; Pastorelli L; Papi C; Castiglione F; Angelucci E; Pica R; Di Paolo MC; D'Incà R
J Crohns Colitis; 2010 Sep; 4(3):291-300. PubMed ID: 21122518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
